TEST DIRECTORY

AminoIndex_®

About AminoIndex_®

AminoIndex_® is a test that elucidates the current health conditions and the possibility of having a disease based on the balance of various blood amino acids. The analysis using AminoIndex_® is outsourced to Ajinomoto Co., Inc.

About AIRS_® (AminoIndex_® Risk Screening)

AIRS_® is a test using AminoIndex_® that evaluates current and future risk of having various diseases at once based on the blood amino acid balance from a single blood collection.

About AICS_® (AminoIndex_® Cancer Screening)

AICS_® is a test using AminoIndex_® that evaluates the current possibility of having cancer.

Male AICS 5 types: Gastric cancer, lung cancer, colorectal cancer, pancreatic cancer, prostate cancer

Female AICS 6 types: Gastric cancer, lung cancer, colorectal cancer, pancreatic cancer, breast cancer, uterine cancer (cervical cancer, endometrial cancer), ovarian cancer

About AILS_® (AminoIndex_® LifeStyle diseases)

Based on the blood amino acid balance, AILS_® evaluates the risk of developing stroke or myocardial infarction within 10 years, risk of developing diabetes within 4 years, low levels of blood essential or semi-essential amino acids, and the current possibility of cognitive decline, and reports types I-IV, and types I*-IV* based on the test results.

In addition, evaluation information regarding lifestyle improvement can be provided based on these types. Please note in advance that AILS® cannot be accepted alone.

Notes on AIRS_® and AICS_®

AIRS_® is a test developed for Japanese people (excluding pregnant women) of the following ages. Other individuals are not targeted for evaluation.

• In the case of stroke patients, myocardial infarction patients, diabetes patients, dementia patients, and patients with mild cognitive impairment (all of whom have been diagnosed or are being treated at medical institutions), while AILS values and lifestyle improvement types regarding the disease/findings are output, none of them are targeted for evaluation.
• For pregnant women, lactating women, cancer patients (including those being treated), patients with congenital metabolic disorders, and dialysis patients, please refrain from having the test performed as it may affect test results. Please note in advance that those aged 49 or less cannot select AILS (Cognitive decline).
• Please avoid consuming anything other than water (food, supplements, etc.) within 8 hours prior to the test, and collect blood by 12:00. (Avoid high-protein diet as well the day before the test.) In addition, refrain from exercise on the morning of the test.
• The effect of drugs on this test is unknown.
• Please avoid duplicate requests for other items.
• Specimens with severe hemolysis or materials other than plasma (EDTA-2Na) cannot be accepted.
• Be sure to specify your gender and age when requesting.

About specimen handling

1. Collect approximately 5 mL of blood using the blood collection tube containing EDTA-2Na.
2. Immediately after collection, mix the blood by inverting it lightly 2 to 3 times. (Avoid using a roller.)
3. Immediately (within 1 minute) after mixing, cool the blood collection tube in ice water at least 15 minutes until centrifugation, in such a way that the tube is submerged up to the liquid level of the blood.
4. Centrifuge under cooled conditions (4℃, 3000 rpm, 15 minutes) or normal conditions (3000 rpm, 15 minutes, the rotor must not be warmed) within 8 hours of collection.
5. Immediately after centrifugation, collect the supernatant plasma from its center without touching the interface with blood, and then dispense it.
6. After dispensing, freeze the plasma within 4 hours.